Saudi investors exit Pakistan’s largest pharmacy chain. What happened and why?
From its origins as part of the Servis Group to multiple changes in ownership since its inception in 2005, Servaid has undergone an eventful two decades in existence
Pharmaceuticals: how the locals are beating the multinationals
In a heavily regulated market, the local players have learned to live with the price rules the way they are, while the foreign players still seem to have hope that things will change
The magic pill for the pharma sector
Will the deregulation in drug pricing policy prove to be the long awaited cure for the pharmaceutical industry?
OBS Pakistan amalgamates AGP with AitkenStuart
It is pertinent to mention that rumours had been circulating that OBS Pakistan was going through major restructuring and this acquisition by Searle comes as a surprise for the market.
The mechanics behind the panadol shortage
Raids, hoarding and over regulating — You probably need a Panadol to figure out what’s going on
Where did all the Burnol go?
The household product is missing from pharmacies in Pakistan. But its brand recall still holds
Seasonal flu pushing up rates of Arinac Forte, Panadol CF
KARACHI: As seasonal flu sets in, demand has surged for Arinac Forte and Panadol CF , used for cold and flu and witnessed...
Is Treet Corporation Pakistan’s next big conglomerate?
Syed Sheharyar Ali is now the fourth generation of his family to be a major business owner in the region that is...
Pricing dispute causes shortage of critical medicine
Pharma companies stop, limit production of scores of essential and non-essential medicines as govt rejects demand for 38% hike in prices
AGP acquires portfolio of products from American pharma firm Viatris
AGP claims newly acquired products will add Rs20b to annual revenues
Pakistan’s medicinal imports rise by 9.74pc
ISLAMABAD: Pakistan imported medicinal product worth $656.092 million during the first seven months of current fiscal year, showing growth of 9.74 per...
Pfizer looks beyond COVID sales with $43b deal for cancer drugmaker Seagen
WASHNGTON: Pfizer Inc on Monday struck a roughly $43 billion deal for Seagen Inc to bulk up its cancer treatments portfolio, as...
PPMA vs DRAP: Pharma crisis continuesÂ
Unavailability of medicines could inevitably trigger national health emergency
Ferozsons dissociates itself from marketing of unlicensed Covid-19 treatment imported from Bangladesh
Ferozsons Laboratories Limited has dissociated itself from the launch of an unlicensed treatment for Covid-19, being imported from Bangladesh.
Clarifying its position, the...
Trump vows to reduce US drug prices to world’s lowest
WASHINGTON: US President Donald Trump on Friday said his administration is working on an executive order to reduce US drug prices to...